DOCK3

Chr 3AR

dedicator of cytokinesis 3

Also known as: MOCA, NEDIDHA, PBP

This gene is specifically expressed in the central nervous system (CNS). It encodes a member of the DOCK (dedicator of cytokinesis) family of guanine nucleotide exchange factors (GEFs). This protein, dedicator of cytokinesis 3 (DOCK3), is also known as modifier of cell adhesion (MOCA) and presenilin-binding protein (PBP). The DOCK3 and DOCK1, -2 and -4 share several conserved amino acids in their DHR-2 (DOCK homology region 2) domains that are required for GEF activity, and bind directly to WAVE proteins [Wiskott-Aldrich syndrome protein (WASP) family Verprolin-homologous proteins] via their DHR-1 domains. The DOCK3 induces axonal outgrowth in CNS by stimulating membrane recruitment of the WAVE complex and activating the small G protein Rac1. This gene is associated with an attention deficit hyperactivity disorder-like phenotype by a complex chromosomal rearrangement. [provided by RefSeq, Aug 2010]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.161 OMIM phenotype
Clinical SummaryDOCK3
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
14 unique Pathogenic / Likely Pathogenic· 233 VUS of 341 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.16LOEUF
pLI 1.000
Z-score 9.00
OE 0.10 (0.060.16)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.94Z-score
OE missense 0.67 (0.630.71)
766 obs / 1139.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.10 (0.060.16)
00.351.4
Missense OE?0.67 (0.630.71)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 11 / 115.3Missense obs/exp: 766 / 1139.9Syn Z: -0.00
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateDOCK3-related neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.3991th %ile
GOF
0.5171th %ile
LOF
0.66top 25%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

341 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic6
VUS233
Likely Benign44
Benign4
Conflicting3
8
Pathogenic
6
Likely Pathogenic
233
VUS
44
Likely Benign
4
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
7
0
1
0
8
Likely Pathogenic
6
0
0
0
6
VUS
6
224
3
0
233
Likely Benign
0
8
3
33
44
Benign
0
1
2
1
4
Conflicting
3
Total19233934298

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

11 pathogenic / likely-pathogenic (of 17) ClinVar copy-number / structural variants overlap DOCK3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

DOCK3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →